HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CNTO 528 monoclonal antibody

may be an effective therapy for patients with anemia

Also Known As:

CNTO 528; monoclonal antibody CNTO 528

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        CNTO 528 monoclonal antibody: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        CNTO 528 monoclonal antibody: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        CNTO 528 monoclonal antibody: 1

Experts

1.	Bai, Stephen A: 1 article (10/2008)
2.	Bouman-Thio, Esther: 1 article (10/2008)
3.	Burggraaf, Jacobus: 1 article (10/2008)
4.	Cohen, Adam: 1 article (10/2008)
5.	Davis, Hugh: 1 article (10/2008)
6.	Franson, Kari: 1 article (10/2008)
7.	Frederick, Bart: 1 article (10/2008)
8.	Getsy, John: 1 article (10/2008)
9.	Jang, Haishan: 1 article (10/2008)
10.	Jiao, Qun: 1 article (10/2008)

Related Diseases

1.	Anemia 10/01/2008 - "In this first-in-human study, CNTO 528 was well tolerated and effective in elevating and maintaining Hgb by at least 1 g/dL following a single intravenous administration, which suggests that an erythropoietin mimetic molecule, such as CNTO 528, may be an effective therapy for patients with anemia."

Related Drugs and Biologics

1.	Erythropoietin

Related Therapies and Procedures

1.	Intravenous Administration
2.	Therapeutics